Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Aino Palva"'
Autor:
Johanna Lehtonen, Anna-Maija Sulonen, Henrikki Almusa, Vilma-Lotta Lehtokari, Mridul Johari, Aino Palva, Anna H. Hakonen, Kirmo Wartiovaara, Anna-Elina Lehesjoki, Bjarne Udd, Carina Wallgren-Pettersson, Katarina Pelin, Marco Savarese, Janna Saarela
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Rare or novel missense variants in large genes such as TTN and NEB are frequent in the general population, which hampers the interpretation of putative disease-causing biallelic variants in patients with sporadic neuromuscular disorders. Oft
Externí odkaz:
https://doaj.org/article/43e5137fe16b43bb8cfbbc8eaa443ea1
Autor:
Hanna Vauhkonen, Phuoc Truong Nguyen, Ravi Kant, Ilja Plyusnin, Mert Erdin, Satu Kurkela, Hanna Liimatainen, Niina Ikonen, Soile Blomqvist, Kirsi Liitsola, Erika Lindh, Otto Helve, Hanna Jarva, Raisa Loginov, Aino Palva, Tiina Hannunen, Sari Hannula, Mikko Parry, Paula Kauppi, Antti Vaheri, Tarja Sironen, Maija Lappalainen, Carita Savolainen-Kopra, Teemu Smura, Olli Vapalahti
Publikováno v:
Emerging Infectious Diseases, Vol 28, Iss 6, Pp 1229-1232 (2022)
Multiple introductions of SARS-COV-2 Omicron variant BA.1 and BA.1.1. lineages to Finland were detected in early December 2021. Within 3 weeks, Omicron overtook Delta as the most common variant in the capital region. Sequence analysis demonstrated th
Externí odkaz:
https://doaj.org/article/7758930069f940efbf0601d560be8ab2
Autor:
Krister Wennerberg, Olli Kallioniemi, Kimmo Porkka, Caroline A. Heckman, Tero Aittokallio, Jonathan Knowles, Maija Wolf, Imre Västrik, Laura Turunen, Minna Suvela, Maria E. Rämet, Tero Pirttinen, Alun Parsons, Aino Palva, Satu Mustjoki, Astrid Murumägi, Pirkko Mattila, Jesus M. Lopez Marti, Muntasir Mamun Majumder, Tuija Lundán, Maija Lepistö, Anna Lehto, Sonja Lagström, Evgeny Kulesskiy, Riikka Karjalainen, Bjørn T. Gjertsen, Erkki Elonen, Pekka Ellonen, Maxim M. Bespalov, Henrikki Almusa, Agnieszka Szwajda, Samuli Eldfors, Henrik Edgren, Bhagwan Yadav, Mika Kontro, Tea Pemovska
XLSX file 452K, DSRT Oncology drug collection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d3d9a1a3b523ca3e416409b924c68ae
https://doi.org/10.1158/2159-8290.22528544
https://doi.org/10.1158/2159-8290.22528544
Autor:
Krister Wennerberg, Olli Kallioniemi, Kimmo Porkka, Caroline A. Heckman, Tero Aittokallio, Jonathan Knowles, Maija Wolf, Imre Västrik, Laura Turunen, Minna Suvela, Maria E. Rämet, Tero Pirttinen, Alun Parsons, Aino Palva, Satu Mustjoki, Astrid Murumägi, Pirkko Mattila, Jesus M. Lopez Marti, Muntasir Mamun Majumder, Tuija Lundán, Maija Lepistö, Anna Lehto, Sonja Lagström, Evgeny Kulesskiy, Riikka Karjalainen, Bjørn T. Gjertsen, Erkki Elonen, Pekka Ellonen, Maxim M. Bespalov, Henrikki Almusa, Agnieszka Szwajda, Samuli Eldfors, Henrik Edgren, Bhagwan Yadav, Mika Kontro, Tea Pemovska
PDF file 400K, Supplementary Figures 1-9; Supplementary Tables 4-9 and Supplementary Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46538d99dce5bf5e0626b55a4e516035
https://doi.org/10.1158/2159-8290.22528547
https://doi.org/10.1158/2159-8290.22528547
Autor:
Hanna Vauhkonen, Phuoc Truong, Ravi Kant, Ilja Plyusnin, Mert Erdin, Satu Kurkela, Hanna Liimatainen, Niina Ikonen, Soile Blomqvist, Kiirsi Liitsola, Erika Lindh, Otto Helve, Hanna Jarva, Raisa Longinov, Aino Palva, Tiina Hannunen, Sari Hannula, Mikko Parry, Paula Kauppi, Antti Vaheri, Tarja Sironen, Maija Lappalainen, Carita Savolainen-Kopra, Teemu Smura, Olli Vapalahti
Multiple introductions of SARS-COV-2 Omicron variant BA.1. and BA.1.1. lineages to Finland were detected early December 2021, and comprised the majority over Delta variant in 3 weeks in the capital region. Our sequence analysis demonstrates emergence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad9b68813f496faecc69a9a6d136767a
https://doi.org/10.21203/rs.3.rs-1480433/v1
https://doi.org/10.21203/rs.3.rs-1480433/v1
Autor:
Disha Malani, Olli Kallioniemi, Alun Parson, Satu Mustjoki, Minna Suvela, Caroline A. Heckman, Katja Suomi, Karoliina Laamanen, Laura Turunen, Kimmo Porkka, Ashwni Kumar, Bjørn Tore Gjertsen, Imre Vastrik, Muntasir Mamun Majumder, Pekka Ellonen, Evgeny Kulesskiy, Maija Wolf, Maria Nurmi, Oscar Brück, Astrid Muruimägi, Swapnil Potdar, Sari Kytölä, Krister Wennerberg, Samuli Eldfors, Tero Aittokallio, Simon Anders, Riikka Karjalainen, Bhagwan Yadav, Jani Saarela, Siv Knappila, Matti Kankainen, Aino Palva, Elina Lehtinen, Mika Kontro, Pirkko Mattila
Publikováno v:
Cancer Research. 79:458-458
Acute myeloid leukemia (AML) is an aggressive disease of clonal hematopoietic progenitor cells. Here, we applied ex-vivo drug sensitivity and resistance testing on AML patient cells with 362 emerging and 153 approved cancer drugs together with genomi
Autor:
Siv Knappila, Matti Kankainen, Aino Palva, Piia Mikkonen, Maria Nurmi, Imre Vastrik, Mika Kontro, Karjalainen Riikka, Sanna Timonen, Satu Mustjoki, Krister Wennerberg, Disha Malani, Maija Wolf, Oscar Brück, Pekka Ellonen, Ashwini Kumar, Tero Aittokallio, Pirkko Mattila, Laura Turunen, Caroline A. Heckman, Bhagwan Yadav, Karoliina Laamanen, Kimmo Porkka, Sari Kytölä, Swapnil Potdar, Alun Parson, Poojitha Ojamies, Astrid Murumägi, Evgeny Kulesskiy, Bjorn Tore Gjersten, Olli Kallioniemi, Muntasir Mamun Majumder, Minna Suvela, Jani Saarela, Samuli Eldfors, Simon Anders, Elina Lehtinen
Publikováno v:
Cancer Research. 78:3899-3899
Acute myeloid leukemia (AML) is a heterogeneous disease characterized by multiple molecular subtypes and lack of effective targeted therapies. Here, we performed extensive molecular profiling and ex vivo drug testing with 515 approved and emerging ca
Autor:
Jonathan Knowles, Erkki Elonen, Laura Turunen, Tero Aittokallio, Maria E. Rämet, Kimmo Porkka, Satu Mustjoki, Aino Palva, Pekka Ellonen, Henrikki Almusa, Mika Kontro, Samuli Eldfors, Tuija Lundán, Caroline A. Heckman, Tea Pemovska, Agnieszka Szwajda, Bhagwan Yadav, Maija Lepistö, Tero Pirttinen, Anna Lehto, Krister Wennerberg, Maxim M. Bespalov, Olli Kallioniemi, Muntasir Mamun Majumder, Sonja Lagström, Jesus M. Lopez Marti, Minna Suvela, Imre Vastrik, Maija Wolf, Pirkko Mattila, Henrik Edgren, Astrid Murumägi, Evgeny Kulesskiy, Bjørn Tore Gjertsen, Alun Parsons, Riikka Karjalainen
Publikováno v:
Cancer Discovery. 3:1416-1429
We present an individualized systems medicine (ISM) approach to optimize cancer drug therapies one patient at a time. ISM is based on (i) molecular profiling and ex vivo drug sensitivity and resistance testing (DSRT) of patients' cancer cells to 187
Autor:
Riikka Karjalainen, Maija Lepistö, Tero Pirttinen, Jonathan Knowles, Maxim M. Bespalov, Samuli Eldfors, Sonja Lagström, Erkki Elonen, Anna Lehto, Bjørn Tore Gjertsen, Jesus M. Lopez Marti, Aino Palva, Alun Parsons, Tea Pemovska, Satu Mustjoki, Maria E. Rämet, Kimmo Porkka, Agnieszka Szwajda, Laura Turunen, Mika Kontro, Krister Wennerberg, Astrid Murumägi, Evgeny Kulesskiy, Pekka Ellonen, Pirkko Mattila, Caroline A. Heckman, Olli Kallioniemi, Minna Suvela, Imre Vastrik, Tero Aittokallio, Maija Wolf, Tuija Lundán, Henrik Edgren, Muntasir Mamun Majumder, Bhagwan Yadav, Henrikki Almusa
Publikováno v:
ResearcherID
Introduction Adult acute myeloid leukemia (AML) exemplifies the challenges of modern cancer drug discovery and development in that molecularly targeted therapies are yet to be translated into clinical use. No effective second-line therapy exists once
Autor:
Lehtonen, Johanna1,2,3,4 (AUTHOR), Sulonen, Anna-Maija2 (AUTHOR), Almusa, Henrikki2 (AUTHOR), Lehtokari, Vilma-Lotta3,4 (AUTHOR), Johari, Mridul3,4,5 (AUTHOR), Palva, Aino2 (AUTHOR), Hakonen, Anna H.6 (AUTHOR), Wartiovaara, Kirmo6 (AUTHOR), Lehesjoki, Anna-Elina3,4 (AUTHOR), Udd, Bjarne3,4 (AUTHOR), Wallgren-Pettersson, Carina3,4 (AUTHOR), Pelin, Katarina3,4,7 (AUTHOR), Savarese, Marco3,4 (AUTHOR), Saarela, Janna1,2,8 (AUTHOR) j.s.saarela@ncmm.uio.no
Publikováno v:
Scientific Reports. 2/21/2024, Vol. 14 Issue 1, p1-11. 11p.